| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 113,852 | 115,911 | 120,873 | 117,311 | | Cost of Revenue | 15,324 | 17,152 | 18,927 | 22,802 | | | Gross Profit |
-
| 98,759 | 101,946 | 94,509 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,640 | 59,233 | 48,394 | 46,581 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 38,000 | 35,640 | 49,032 | 83,892 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,886 | 4,520 | (35,964) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,888 | 3,886 | 4,520 | (35,964) | | Interest Expense | 6,457 | 7,596 | 8,334 | 10,118 | | Income Before Tax | (2,569) | (3,710) | (3,814) | (46,082) | | Income Tax Expense | (5,920) | (6,373) | (9,541) | (19,192) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,351 | 2,663 | 5,727 | (26,890) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,351 | 2,663 | 5,727 | (26,890) | | Preferred Stock And Other Adjustments | (2,524) | (2,600) | (2,572) | (712) | | | Net Income Applicable To Common Shares | $773 | $63 | $3,155 | ($27,602) |
|
0.51% Nasdaq 
Income Statement
